TD Cowen names UnitedHealth its 2027 best idea, upgrades shares
TD Cowen upgraded UnitedHealth Group to Buy, naming it its 2027 Best Idea. The brokerage raised its price target to $455, citing improved earnings outlook and stronger margins. It expects adjusted EPS to grow to $23.57 in 2027 and $27.61 in 2028, driven by Optum Health recovery and Medicare Advantage profitability.
How this was made
The 30-second read
Why it matters
The key trading hook is the combination of an upgrade, a raised price target, and a detailed multi-year earnings/margin bridge that can influence short-term positioning and expectations.
Market read
For traders, this is a sentiment and expectations reset anchored to Optum Health margin recovery and higher modeled EPS through 2028.
What to watch
Regulatory and reimbursement dynamics in Medicare Advantage and Medicaid, plus execution risk in Optum Rx/Insight growth, could limit the realized path to mid-to-high-teens earnings growth.
Background
TD Cowen’s note reframes UnitedHealth’s earnings outlook around Optum Health stabilization and margin normalization across insurance and government programs.
Ticker impact
TD Cowen upgraded UnitedHealth to Buy and named it its 2027 Best Idea, citing an improving earnings outlook tied to Optum Health recovery and margin gains.
Likely upward bias as traders price in the revised earnings trajectory and higher target, though follow-through depends on whether the market already anticipated the Optum recovery.
The article contains a concrete analyst action (upgrade plus raised price target) and a specific earnings bridge (Optum Health margin expansion and profitability recovery) that can drive near-term sentiment and positioning.
Market effects
Reinforces positive read-through for managed care and Optum-linked earnings durability, potentially supporting sentiment across large US health insurers.
primarily US large-cap healthcare sentiment; limited direct cross-region impact.
modest, as the catalyst is company-specific analyst guidance rather than a global policy or macro shock.
Counterpoint
The upgrade may be more about analyst modeling than new company disclosures; if Optum margin recovery or Medicare Advantage profitability faces headwinds, the thesis could unwind.
Key entities
- companyUnitedHealth Group
Subject of the analyst upgrade and Best Idea call, with thesis centered on Optum Health recovery and margin expansion.
- analyst_firmTD Cowen
Brokerage issuing the Buy upgrade, raised price target, and 2027 Best Idea designation.


